Qube Research & Technologies LTD Catalent, Inc. Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Catalent, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 827,758 shares of CTLT stock, worth $52.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

827,758

Previous 27 3065670.37%

Holding current value

$52.5 Million

Previous $1,000 5013600.0%

% of portfolio

0.08%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$56.16 - $60.96 $46.5 Million - $50.5 Million	827,731 Added 3065670.25%	827,758 $50.1 Million
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $4.28 Million - $4.56 Million	-79,923 Reduced 99.97%	27 $1,000
Q1 2024 May 14, 2024	BUY	$42.56 - $59.82 $3.25 Million - $4.57 Million	76,326 Added 2106.13%	79,950 $4.51 Million
Q4 2023 Feb 13, 2024	BUY	$32.18 - $46.57 $1,319 - $1,909	41 Added 1.14%	3,624 $162,000
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $158,368 - $179,866	3,583 New	3,583 $163,000
Q1 2022 May 09, 2022	SELL	$94.19 - $124.49 $6.67 Million - $8.81 Million	-70,783 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$119.57 - $139.07 $1.38 Million - $1.6 Million	-11,529 Reduced 14.01%	70,783 $9.06 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $498,906 - $650,539	4,570 Added 5.88%	82,312 $11 Million
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $7.2 Million - $8.31 Million	71,798 Added 1207.91%	77,742 $8.41 Million
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $603,375 - $744,604	5,944 New	5,944 $626,000
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $4.63 Million - $5.69 Million	-53,966 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $3.93 Million - $4.99 Million	53,966 New	53,966 $4.62 Million
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $229,679 - $378,048	-4,783 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $176,731 - $301,089	4,783 New	4,783 $248,000
Q4 2019 Feb 13, 2020	SELL	$47.06 - $56.64 $569,378 - $685,287	-12,099 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$47.45 - $58.05 $331,343 - $405,363	6,983 Added 136.49%	12,099 $577,000
Q2 2019 Aug 02, 2019	BUY	$39.26 - $54.21 $200,854 - $277,338	5,116 New	5,116 $277,000
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $167,540 - $259,225	-5,594 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $193,538 - $219,733	4,824 Added 626.49%	5,594 $255,000
Q2 2018 Aug 14, 2018	BUY	$38.72 - $42.52 $29,814 - $32,740	770 New	770 $32,000

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Catalent, Inc. Transaction History